PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway
Open Access
- 26 June 2022
- journal article
- research article
- Published by Association of Basic Medical Sciences of FBIH in Bosnian Journal of Basic Medical Sciences
- Vol. 22 (6), 992-1004
- https://doi.org/10.17305/bjbms.2022.7416
Abstract
Phospholipase C epsilon 1 (PLCE1) is involved in the pathogenesis of many cancers. However, the biological role of PLCE1 in osteosarcoma (OS) is still poorly understood. The prognostic survival analysis was performed on the PLCE1gene in the TARGET data set and the differential expression of PLCE1 in OS tissue and normal bone tissue on the tissue chip was detected by immunohistochemistry. Spearman’s rank correlation coefficient analysis was implemented to explore the relationship between PLCE1 and immune genes. Finally, PLCE1 was silenced to explore its biological function in OS cells. The results of tissue chip immunohistochemistry showed that PLCE1 expression in OS tissue was higher than in normal bone tissue. The survival curve of PLCE1 and its corresponding receiver operating characteristic curve (ROC) showed that PLCE1 had a significant effect on the survival status of patients with OS and that the prognosis of patients with high PLCE1 expression was relatively poor. Spearman’s rank correlation coefficient analysis and qRT-PCR assays found that PLCE1 may promote immune escape from OS via CD70-CD27 signaling pathway. Silencing of PLCE1 causes the following biological behaviors of OS cells: it promotes apoptosis, inhibits proliferation of OS cells, and inhibits the ability of cell migration and invasion. PLCE1 is a poor prognostic marker and a potential key factor affecting the immune status of the OS tumor microenvironment.Keywords
This publication has 49 references indexed in Scilit:
- Distinctive Features of the Differentiated Phenotype and Infiltration of Tumor-Reactive Lymphocytes in Clear Cell Renal Cell CarcinomaCancer Research, 2012
- Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African populationCarcinogenesis: Integrative Cancer Research, 2012
- Role of phospholipase Cε in physiological phosphoinositide signaling networksCellular Signalling, 2012
- The immune score as a new possible approach for the classification of cancerJournal of Translational Medicine, 2012
- Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1Nature Genetics, 2011
- Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1Nature Genetics, 2010
- A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinomaNature Genetics, 2010
- Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversibleNature Genetics, 2006
- Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomasMolecular Cancer Therapeutics, 2005
- CD27 and CD70 in T cell and B cell activationCurrent Opinion in Immunology, 2005